Episode
Bayer Acquires Perfuse in $2.45 Billion Deal
- Podcast
- Eyewire News: The Podcast
- Published
- May 6, 2026
- Duration seconds
- 410
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/BMCL7214816195.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/bayer-acquires-perfuse-in-2-45-billion-deal/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/bayer-acquires-perfuse-in-2-45-billion-deal.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Bayer expands ophthalmology pipeline with acquisiton of Perfuse Therapeutics; Viridian announces new phase 3 data for its investigational subcutaneous injection for chronic thyroid eye disease; and Steven Dell, MD discusses the impact of declining reimbursement could on ophthalmic practices. Learn more about your ad choices. Visit megaphone.fm/adchoices